Robin Bruce has more than 25 years of experience in the in vitro diagnostics industry. Currently, she is Vice President of Program Management for Seegene USA, Inc., the US-based division of Seegene Inc. a global developer of infection disease molecular diagnostic products. Previously, Robin was the Vice President of Program and Product Management for Beckman Coulter Diagnostics, a Danaher Corporation company. During her career, Robin led the development of IVD products for hematology, urinalysis, molecular, clinical chemistry, laboratory automation and clinical information solutions. Robin also led continuous process improvements for business processed for Lean and new product development process for IVD. Robin has a B.S. from California State University, Fullerton.